5-53646367-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002495.4(NDUFS4):​c.312A>G​(p.Arg104Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.77 in 1,613,250 control chromosomes in the GnomAD database, including 479,850 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.79 ( 47554 hom., cov: 31)
Exomes 𝑓: 0.77 ( 432296 hom. )

Consequence

NDUFS4
NM_002495.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.713

Publications

35 publications found
Variant links:
Genes affected
NDUFS4 (HGNC:7711): (NADH:ubiquinone oxidoreductase subunit S4) This gene encodes an nuclear-encoded accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (complex I, or NADH:ubiquinone oxidoreductase). Complex I removes electrons from NADH and passes them to the electron acceptor ubiquinone. Mutations in this gene can cause mitochondrial complex I deficiencies such as Leigh syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
NDUFS4 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, G2P
  • mitochondrial complex I deficiency, nuclear type 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • mitochondrial complex I deficiency, nuclear type
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • Leigh syndrome with leukodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial complex I deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 5-53646367-A-G is Benign according to our data. Variant chr5-53646367-A-G is described in ClinVar as Benign. ClinVar VariationId is 129701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.713 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.844 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDUFS4NM_002495.4 linkc.312A>G p.Arg104Arg synonymous_variant Exon 3 of 5 ENST00000296684.10 NP_002486.1 O43181A0A0S2Z433

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDUFS4ENST00000296684.10 linkc.312A>G p.Arg104Arg synonymous_variant Exon 3 of 5 1 NM_002495.4 ENSP00000296684.5 O43181

Frequencies

GnomAD3 genomes
AF:
0.789
AC:
119917
AN:
151958
Hom.:
47509
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.852
Gnomad AMI
AF:
0.612
Gnomad AMR
AF:
0.806
Gnomad ASJ
AF:
0.735
Gnomad EAS
AF:
0.769
Gnomad SAS
AF:
0.776
Gnomad FIN
AF:
0.754
Gnomad MID
AF:
0.816
Gnomad NFE
AF:
0.761
Gnomad OTH
AF:
0.772
GnomAD2 exomes
AF:
0.775
AC:
194783
AN:
251396
AF XY:
0.774
show subpopulations
Gnomad AFR exome
AF:
0.856
Gnomad AMR exome
AF:
0.804
Gnomad ASJ exome
AF:
0.738
Gnomad EAS exome
AF:
0.773
Gnomad FIN exome
AF:
0.754
Gnomad NFE exome
AF:
0.762
Gnomad OTH exome
AF:
0.764
GnomAD4 exome
AF:
0.769
AC:
1122971
AN:
1461174
Hom.:
432296
Cov.:
49
AF XY:
0.768
AC XY:
558472
AN XY:
726924
show subpopulations
African (AFR)
AF:
0.856
AC:
28643
AN:
33466
American (AMR)
AF:
0.805
AC:
35991
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.734
AC:
19181
AN:
26126
East Asian (EAS)
AF:
0.732
AC:
29054
AN:
39666
South Asian (SAS)
AF:
0.778
AC:
67051
AN:
86238
European-Finnish (FIN)
AF:
0.753
AC:
40199
AN:
53406
Middle Eastern (MID)
AF:
0.773
AC:
4453
AN:
5758
European-Non Finnish (NFE)
AF:
0.766
AC:
851542
AN:
1111442
Other (OTH)
AF:
0.776
AC:
46857
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
13446
26892
40338
53784
67230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20496
40992
61488
81984
102480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.789
AC:
120019
AN:
152076
Hom.:
47554
Cov.:
31
AF XY:
0.790
AC XY:
58678
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.852
AC:
35359
AN:
41506
American (AMR)
AF:
0.806
AC:
12304
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.735
AC:
2553
AN:
3472
East Asian (EAS)
AF:
0.768
AC:
3961
AN:
5156
South Asian (SAS)
AF:
0.775
AC:
3732
AN:
4816
European-Finnish (FIN)
AF:
0.754
AC:
7969
AN:
10562
Middle Eastern (MID)
AF:
0.816
AC:
240
AN:
294
European-Non Finnish (NFE)
AF:
0.761
AC:
51718
AN:
67972
Other (OTH)
AF:
0.769
AC:
1626
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1287
2574
3862
5149
6436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.771
Hom.:
91191
Bravo
AF:
0.794
Asia WGS
AF:
0.777
AC:
2702
AN:
3478
EpiCase
AF:
0.757
EpiControl
AF:
0.763

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 19, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mitochondrial complex I deficiency, nuclear type 1 Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Leigh syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
9.2
DANN
Benign
0.62
PhyloP100
0.71
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs31303; hg19: chr5-52942197; COSMIC: COSV57019407; API